{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T04:45:55Z","timestamp":1790484355391,"version":"4.1.0"},"reference-count":24,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JASN"],"published-print":{"date-parts":[[2019,2]]},"abstract":"\n Significance Statement<\/jats:title>\n How bisphosphonates affect bone quality in kidney transplant recipients is unclear. This study of 34 patients with kidney transplants randomized to receive zoledronate or no treatment for 12 months found that zoledronate did not induce adynamic bone disease; decreased bone turnover experienced by both groups was unaffected by zoledronate. Total hip and lumbar spine bone mineral density increased for both groups, especially at the lumbar spine and femoral neck in the zoledronate group. However, bone biopsies from both groups showed impaired trabecular connectivity, and high-resolution imaging detected trabecular bone loss at peripheral skeleton sites, which zoledronate partially attenuated. Because fractures in patients with transplants are most commonly peripheral fractures, bisphosphonates may be considered for patients with high fracture risk and evidence of bone loss in the peripheral skeleton at the time of transplant.<\/jats:p>\n <\/jats:sec>\n \n Background<\/jats:title>\n Bone and mineral disorders commonly affect kidney transplant (KTx) recipients and have been associated with a high risk of fracture. Bisphosphonates may prevent or treat bone loss in such patients, but there is concern that these drugs might induce adynamic bone disease (ABD).<\/jats:p>\n <\/jats:sec>\n \n Methods<\/jats:title>\n In an open label, randomized trial to assess the safety and efficacy of zoledronate for preventing bone loss in the first year after kidney transplant, we randomized 34 patients before transplant to receive zoledronate or no treatment. We used dual-energy x-ray absorptiometry (DXA), high-resolution peripheral quantitative computed tomography (HR-pQCT), and bone biopsies to evaluate changes in bone in the 32 evaluable participants between the time of KTx and 12 months post-transplant.<\/jats:p>\n <\/jats:sec>\n \n Results<\/jats:title>\n Both groups of patients experienced decreased bone turnover after KTx, but zoledronate itself did not affect this outcome. Unlike previous studies, DXA showed no post-transplant bone loss in either group; we instead observed an increase of bone mineral density in both lumbar spine and total hip sites, with a significant positive effect of zoledronate. However, bone biopsies showed post-transplant impairment of trabecular connectivity (and no benefit from zoledronate); HR-pQCT detected trabecular bone loss at the peripheral skeleton, which zoledronate partially attenuated.<\/jats:p>\n <\/jats:sec>\n \n Conclusions<\/jats:title>\n Current immunosuppressive regimens do not contribute to post-transplant central skeleton trabecular bone loss, and zoledronate does not induce ABD. Because fractures in transplant recipients are most commonly peripheral fractures, clinicians should consider bisphosphonate use in patients at high fracture risk who have evidence of significantly low bone mass at these sites at the time of KTx.<\/jats:p>\n <\/jats:sec>","DOI":"10.1681\/asn.2018060656","type":"journal-article","created":{"date-parts":[[2019,1,3]],"date-time":"2019-01-03T16:45:14Z","timestamp":1546533914000},"page":"355-365","source":"Crossref","is-referenced-by-count":53,"title":["A Randomized Trial of Zoledronic Acid to Prevent Bone Loss in the First Year after Kidney Transplantation"],"prefix":"10.1681","volume":"30","clinical-trial-number":[{"clinical-trial-number":"nct01675089","registry":"10.18810\/clinical-trials-gov"}],"author":[{"given":"Igor Denizarde Bacelar","family":"Marques","sequence":"first","affiliation":[{"name":"Urology Division, Renal Transplant Service and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria J\u00falia Correia Lima Nepomuceno","family":"Ara\u00fajo","sequence":"additional","affiliation":[{"name":"Urology Division, Renal Transplant Service and"},{"name":"Nephrology and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabiana Giorgetti","family":"Graciolli","sequence":"additional","affiliation":[{"name":"Nephrology and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luciene Machado","family":"dos Reis","sequence":"additional","affiliation":[{"name":"Nephrology and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosa Maria R.","family":"Pereira","sequence":"additional","affiliation":[{"name":"Rheumatology Divisions, Hospital das Cl\u00ednicas da Faculdade de Medicina da Universidade de Sao Paulo, Sao Paulo, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jackeline C.","family":"Alvarenga","sequence":"additional","affiliation":[{"name":"Rheumatology Divisions, Hospital das Cl\u00ednicas da Faculdade de Medicina da Universidade de Sao Paulo, Sao Paulo, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melani Ribeiro","family":"Cust\u00f3dio","sequence":"additional","affiliation":[{"name":"Urology Division, Renal Transplant Service and"},{"name":"Nephrology and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vanda","family":"Jorgetti","sequence":"additional","affiliation":[{"name":"Nephrology and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosilene Motta","family":"Elias","sequence":"additional","affiliation":[{"name":"Nephrology and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosa Maria Affonso","family":"Moys\u00e9s","sequence":"additional","affiliation":[{"name":"Nephrology and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elias","family":"David-Neto","sequence":"additional","affiliation":[{"name":"Urology Division, Renal Transplant Service and"},{"name":"Nephrology and"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2019,1,3]]},"reference":[{"key":"B1-20230829","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.2215\/CJN.11371015","article-title":"Bone disease after kidney transplantation.","volume":"11","author":"Bouquegneau","year":"2016","journal-title":"Clin J Am Soc Nephrol"},{"key":"B2-20230829","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1046\/j.1523-1755.2003.00938.x","article-title":"The pathogenesis of osteodystrophy after renal transplantation as detected by early alterations in bone remodeling.","volume":"63","author":"Rojas","year":"2003","journal-title":"Kidney Int"},{"key":"B3-20230829","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1097\/TP.0b013e3182985468","article-title":"Persistence of bone and mineral disorders 2 years after successful kidney transplantation.","volume":"96","author":"Neves","year":"2013","journal-title":"Transplantation"},{"key":"B4-20230829","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1097\/01.TP.0000131990.13277.28","article-title":"Early rapid loss followed by long-term consolidation characterizes the development of lumbar bone mineral density after kidney transplantation.","volume":"77","author":"Brandenburg","year":"2004","journal-title":"Transplantation"},{"key":"B5-20230829","doi-asserted-by":"crossref","first-page":"1882","DOI":"10.1111\/ajt.13692","article-title":"Effect of twice-yearly denosumab on prevention of bone mineral density loss in de novo kidney transplant recipients: A randomized controlled trial.","volume":"16","author":"Bonani","year":"2016","journal-title":"Am J Transplant"},{"key":"B6-20230829","doi-asserted-by":"crossref","first-page":"3316","DOI":"10.1111\/j.1600-6143.2012.04233.x","article-title":"A 1-year randomized, double-blind, placebo-controlled study of intravenous ibandronate on bone loss following renal transplantation.","volume":"12","author":"Smerud","year":"2012","journal-title":"Am J Transplant"},{"key":"B7-20230829","doi-asserted-by":"crossref","first-page":"2669","DOI":"10.1097\/01.ASN.0000087092.53894.80","article-title":"Prevention of bone loss in renal transplant recipients: A prospective, randomized trial of intravenous pamidronate.","volume":"14","author":"Coco","year":"2003","journal-title":"J Am Soc Nephrol"},{"key":"B8-20230829","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1046\/j.1523-1755.2003.00816.x","article-title":"Zoledronic acid to prevent bone loss in the first 6 months after renal transplantation.","volume":"63","author":"Haas","year":"2003","journal-title":"Kidney Int"},{"key":"B9-20230829","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1681\/ASN.2011060623","article-title":"Effect of risedronate on bone in renal transplant recipients.","volume":"23","author":"Coco","year":"2012","journal-title":"J Am Soc Nephrol"},{"key":"B10-20230829","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1097\/01.TP.0000092523.30277.13","article-title":"Prevalence and treatment of decreased bone density in renal transplant recipients: A randomized prospective trial of calcitriol versus alendronate.","volume":"76","author":"Jeffery","year":"2003","journal-title":"Transplantation"},{"key":"B11-20230829","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1053\/j.ajkd.2008.11.036","article-title":"Effect of pamidronate on bone loss after kidney transplantation: A randomized trial.","volume":"53","author":"Walsh","year":"2009","journal-title":"Am J Kidney Dis"},{"key":"B12-20230829","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1007\/s00198-016-3876-0","article-title":"Age-related reference curves of volumetric bone density, structure, and biomechanical parameters adjusted for weight and height in a population of healthy women: An HR-pQCT study.","volume":"28","author":"Alvarenga","year":"2017","journal-title":"Osteoporos Int"},{"key":"B13-20230829","doi-asserted-by":"crossref","first-page":"1839","DOI":"10.1007\/s00198-015-3461-y","article-title":"Bone impairment assessed by HR-pQCT in juvenile-onset systemic lupus erythematosus.","volume":"27","author":"Paupitz","year":"2016","journal-title":"Osteoporos Int"},{"key":"B14-20230829","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1002\/jbmr.2358","article-title":"Longitudinal HR-pQCT and image registration detects endocortical bone loss in kidney transplantation patients.","volume":"30","author":"Nishiyama","year":"2015","journal-title":"J Bone Miner Res"},{"key":"B15-20230829","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1111\/j.1432-2277.2008.00799.x","article-title":"Validation of plasma clearance of 51Cr-EDTA in adult renal transplant recipients: Comparison with inulin renal clearance.","volume":"22","author":"Medeiros","year":"2009","journal-title":"Transpl Int"},{"key":"B16-20230829","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1002\/jbmr.5650020617","article-title":"Bone histomorphometry: Standardization of nomenclature, symbols, and units. Report of the ASBMR Histomorphometry Nomenclature Committee.","volume":"2","author":"Parfitt","year":"1987","journal-title":"J Bone Miner Res"},{"key":"B17-20230829","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1002\/jbmr.309","article-title":"Renal osteodystrophy in the first decade of the new millennium: Analysis of 630 bone biopsies in black and white patients.","volume":"26","author":"Malluche","year":"2011","journal-title":"J Bone Miner Res"},{"key":"B18-20230829","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1038\/sj.ki.5000414","article-title":"Definition, evaluation, and classification of renal osteodystrophy: A position statement from Kidney Disease: Improving Global Outcomes (KDIGO).","volume":"69","author":"Moe","year":"2006","journal-title":"Kidney Int"},{"key":"B19-20230829","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1681\/ASN.2013080851","article-title":"Kidney transplantation with early corticosteroid withdrawal: Paradoxical effects at the central and peripheral skeleton.","volume":"25","author":"Iyer","year":"2014","journal-title":"J Am Soc Nephrol"},{"key":"B20-20230829","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1159\/000168583","article-title":"Reversal of aluminum-related bone disease after renal transplantation.","volume":"13","author":"David-Neto","year":"1993","journal-title":"Am J Nephrol"},{"key":"B21-20230829","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1590\/S0100-879X2006000100004","article-title":"Improvement of adynamic bone disease after renal transplantation.","volume":"39","author":"Abdallah","year":"2006","journal-title":"Braz J Med Biol Res"},{"key":"B22-20230829","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1038\/nrneph.2009.192","article-title":"Bone disease after renal transplantation.","volume":"6","author":"Malluche","year":"2010","journal-title":"Nat Rev Nephrol"},{"key":"B23-20230829","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1007\/s00198-017-3956-9","article-title":"Biopsy vs. peripheral computed tomography to assess bone disease in CKD patients on dialysis: Differences and similarities.","volume":"28","author":"Marques","year":"2017","journal-title":"Osteoporos Int"},{"key":"B24-20230829","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1111\/j.1600-6143.2011.03872.x","article-title":"Reduced fracture risk with early corticosteroid withdrawal after kidney transplant.","volume":"12","author":"Nikkel","year":"2012","journal-title":"Am J Transplant"}],"container-title":["Journal of the American Society of Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00001751-201902000-00016","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T19:31:12Z","timestamp":1786131072000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00001751-201902000-00016"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1,3]]},"references-count":24,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2019]]}},"URL":"https:\/\/doi.org\/10.1681\/asn.2018060656","relation":{},"ISSN":["1046-6673","1533-3450"],"issn-type":[{"value":"1046-6673","type":"print"},{"value":"1533-3450","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,1,3]]}}}